The global market for acute bacterial skin infection therapies is being influenced by rising disease incidence, growing awareness of infection management, and the challenge of treating antibiotic-resistant bacteria. Healthcare systems require effective options for infections caused by pathogens such as MRSA, making continued investment in antibacterial research important. The Acute Bacterial...
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek